Related Experiment Video
Updated: Aug 26, 2025

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
An update on inhibitors targeting RNA-dependent RNA polymerase for COVID-19 treatment: Promises and challenges
Xiaoying Xu1, Yuheng Chen2, Xinyu Lu3
1School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Abstract:
The highly transmissible variants of SARS-CoV-2, the causative pathogen of the COVID-19 pandemic, bring new waves of infection worldwide. Identification of effective therapeutic drugs to combat the COVID-19 pandemic is an urgent global need. RNA-dependent RNA polymerase (RdRp), an essential enzyme for viral RNA replication, is the most promising target for antiviral drug research since it has no counterpart in human cells and shows the highest conservation across coronaviruses. This review summarizes recent progress in studies of RdRp inhibitors, focusing on interactions between these inhibitors and the enzyme complex, based on structural analysis, and their effectiveness. In addition, we propose new possible strategies to address the shortcomings of current inhibitors, which may guide the development of novel efficient inhibitors to combat COVID-19.
Insights
This review explores RNA-dependent RNA polymerase (RdRp) inhibitors as potential COVID-19 therapeutics. It analyzes inhibitor interactions and effectiveness, proposing strategies for developing new antiviral drugs against SARS-CoV-2 variants.
Area of Science:
- Virology
- Drug Discovery
- Structural Biology
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, necessitates urgent development of effective therapeutic drugs.
- Highly transmissible SARS-CoV-2 variants continue to drive global infection waves.
- RNA-dependent RNA polymerase (RdRp) is a conserved and essential viral enzyme, making it a prime target for antiviral therapies.
Purpose of the Study:
- To review recent advancements in the study of RNA-dependent RNA polymerase (RdRp) inhibitors.
- To analyze the structural interactions between RdRp inhibitors and the enzyme complex.
- To evaluate the effectiveness of current RdRp inhibitors and propose future development strategies.
Main Methods:
- Literature review of studies on RdRp inhibitors.
- Analysis of structural data detailing inhibitor-enzyme interactions.
- Assessment of inhibitor efficacy against SARS-CoV-2.
Main Results:
- RdRp is a highly conserved enzyme across coronaviruses and a promising target for antiviral drug development.
- Structural analysis reveals key interactions between inhibitors and the RdRp enzyme complex.
- Current inhibitors show varying degrees of effectiveness, highlighting the need for improved strategies.
Conclusions:
- RdRp inhibitors represent a critical avenue for combating COVID-19.
- Understanding structural interactions is key to designing potent and specific inhibitors.
- Further research into novel strategies is essential for developing next-generation SARS-CoV-2 therapeutics.
More Related Videos
12:03Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Related Concept Videos
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Experimental RNAi
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Viruses with RNA Genomes